INTS•benzinga•
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data In Sarcoma And An Overview Of Its Ongoing Global Randomized Phase 3 Sarcoma Trial In A Late-Breaking Session At The 2024 Annual Connective Tissue Oncology Society Meeting; Phase 1/2 Data Showed A Med
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2024 by benzinga